Disclosed are immunogenic Clostridium difficile cell surface polysaccharides. PS-II is a repeating hexasaccharide unit and PS-1 is a repeating pentasaccharide unit. The polysaccharides can be used in vaccines for treating C. difficile infection and associated diarrhoea in a subject.